The U.S. Centers for Disease Control and Prevention said on Monday that it has received rare reports of Guillain-Barré syndrome among people who got Johnson & Johnson’s Janssen shot. The vaccine has been approved in Canada but never used.
J&J COVID vaccine may pose ‘small possible risk’ of rare neurological syndrome, CDC says
